1-5 of 5
veno-occlusive disease
Close
Sort by
Journal Articles

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Hiroyuki Matsui, Yasuyuki Arai, Hiroharu Imoto, Takaya Mitsuyoshi, Naoki Tamura, Tadakazu Kondo, Junya Kanda, Takayuki Ishikawa, Kazunori Imada, Yasunori Ueda, Yusuke Toda, Naoyuki Anzai, Kazuhiro Yago, Masaharu Nohgawa, Akihito Yonezawa, Hiroko Tsunemine, Mitsuru Itoh, Kazuyo Yamamoto, Masaaki Tsuji, Toshinori Moriguchi, Akifumi Takaori-Kondo, Kyoto Stem Cell Transplantation Group (KSCTG)
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3169–3179.
https://doi.org/10.1182/bloodadvances.2020002007
Published: 2020
Includes: Supplemental data
Journal Articles

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity

Clinical Trials & Observations
Ankur Varma, Susan C. Abraham, Rohtesh S. Mehta, Neeraj Y. Saini, Medhavi Honhar, Munazza Rashid, Julianne Chen, Samer A. Srour, Qaiser Bashir, Gabriela Rondon, Betul Oran, Chitra M. Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, Sairah Ahmed, David Marin, Issa F. Khouri, Stefan O. Ciurea, Muzaffar H. Qazilbash, Katy Rezvani, Paolo Anderlini, Borje S. Andersson, Elizabeth J. Shpall, Richard E. Champlin, Uday R. Popat
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1296–1306.
https://doi.org/10.1182/bloodadvances.2019000638
Published: 2020
Journal Articles

Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia

Clinical Trials & Observations
Joseph Wynne, David Wright, Wendy Stock
Journal: Blood Advances
Blood Adv (2019) 3 (1): 96–104.
https://doi.org/10.1182/bloodadvances.2018026211
Published: 2019
Journal Articles

The use of defibrotide in blood and marrow transplantation

Clinical Trials & Observations
Paul G. Richardson, Enric Carreras, Massimo Iacobelli, Bijan Nejadnik
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1495–1509.
https://doi.org/10.1182/bloodadvances.2017008375
Published: 2018
Journal Articles

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

Clinical Trials & Observations
Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1167–1180.
https://doi.org/10.1182/bloodadvances.2016001925
Published: 2017
Includes: Supplemental data